According to the New York Times, the Pharmaceutical Research and Manufacturers of America will spend $150 million specifically boosting for the health care reform proposal introduced last week by Sen. Max Baucus (D-MT).
PhRMA has already spent millions on ads supporting the idea of reform more generically. But now that Baucus has come forward with an industry friendly proposal of his own–one that’s significantly less progressive than the other proposals in Congress–PhRMA’s throwing it’s weight specifically behind his plan.
Baucus will unveil a draft of his legislation this week, and begin hearings on it next week. His legislation will not include a public health insurance option.
